The page includes details of the researched scientific benefits and a comparison with Melanotan 2
Available from URL: (accessed February 2026) Kindel TL, Wang AY, Wadhwa A, et al
The US Food and Drug Administration (FDA) has approved oral and intravenous (IV) L-carnitine for the treatment of primary and secondary carnitine deficiency as a result of inborn errors of metabolism
All patients suspected of having an eating disorder should be referred to a specialist for a comprehensive assessment of eating disorder psychopathology before initiating obesity treatment
to present positive Phase 2a Results of ROSE-010 at #ObesityWeek2025 Poster presentation will highlight blinded, placebo-controlled data on mealtime food intake, caloric reduction, satiety, GI tolerability, safety, and weight loss
Efficacy was assessed among all randomized participants regardless of treatment discontinuation or rescue intervention